Molecular Imaging

Molecular imaging is a diagnostic imaging procedure that provides detailed images of how the body is funtioning at the molecular and cellular level. It also includes nuclear imaging.

A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese patients with a higher sensitivity and specificity compared to 99Tc-SPECT myocardial perfusion imaging (MPI)

News | SNMMI

Novel Radiotracer Demonstrates High Diagnostic Efficacy for Obese Patients with Coronary Artery Disease

June 28, 2023 — A novel PET perfusion radiotracer, 18F-flurpiridaz, can diagnose coronary artery disease (CAD) in obese ...

June 28, 2023

Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited, announced the clearance by the FDA to use its RUBY Rubidium Elution System and RUBY-FILL (Rubidium Rb82 generator) in mobile settings.

News | Cardiac Imaging

Jubilant Radiopharma Introduces RUBY Mobile Solutions

June 26, 2023 — Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited ...

June 26, 2023

A University of Waterloo engineer’s MRI invention reveals better than many existing imaging technologies how COVID-19 can change the human brain.

News | Coronavirus (COVID-19)

New Imaging Technique Captures COVID-19’s Impact on the Brain

June 14, 2023 — A University of Waterloo engineer’s MRI invention reveals better than many existing imaging technologies ...

June 14, 2023

Patients infected with beta and delta COVID-19 variants, and those who required hospital stays for COVID-19 infection, were more likely to experience heart issues associated with long COVID

News | Coronavirus (COVID-19)

New Analysis Shows COVID Variant and Severity of Illness Influence Cardiac Dysfunction, a Key Indicator of Long COVID

June 9, 2023 — Patients infected with beta and delta COVID-19 variants, and those who required hospital stays for COVID ...

June 09, 2023

The 2023 Multimodality Appropriate Use Criteria (AUC) for the Detection and Risk Assessment of Chronic Coronary Disease is now available online. The new document updates the 2013 AUC and includes several shifts in terminology.

News | SPECT Imaging

Societies Update Multimodality AUC: SPECT and PET Appropriate for Many Patients

June 5, 2023 — The 2023 Multimodality Appropriate Use Criteria (AUC) for the Detection and Risk Assessment of Chronic ...

June 05, 2023

A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin medication was found to reduce the increased risk of cardiovascular disease among people living with HIV in the first large-scale clinical study to test a primary cardiovascular prevention strategy in this population

News | Radiopharmaceuticals and Tracers

Daily Statin Reduces the Risk of Cardiovascular Disease in People Living with HIV, Large NIH Study Finds

April 13, 2023 — A National Institutes of Health (NIH) clinical trial was stopped early because a daily statin ...

April 13, 2023

Researchers found evidence of heart muscle inflammation in a small number of patients with acute myocarditis after COVID-19 vaccination, but not in patients without acute myocarditis

News | Coronavirus (COVID-19)

Study Examines Heart Inflammation after COVID Vaccine

March 10, 2023 — Researchers found evidence of heart muscle inflammation in a small number of patients with acute ...

March 10, 2023

Life Molecular Imaging (LMI) announced that the first patient has been imaged with [18F]florbetaben in the CArdiag Phase 3 clinical study

News | Cardiovascular Clinical Studies

Life Molecular Imaging Announces Start of Phase 3 Study with [18F]Florbetaben in Cardiac Amyloid Light Chain (AL) Amyloidosis

February 8, 2023 — Life Molecular Imaging (LMI) announced that the first patient has been imaged with [18F]florbetaben i ...

February 08, 2023

ASNC releases comprehensive tool for assessing quality, setting meaningful goals, improving patient care in SPECT MPI laboratories

News | Cardiac Imaging

New Guide Will Change How Cardiac Imagers Approach Quality Improvement

January 13, 2023 — Nuclear stress testing performed with single-photon emission computed tomography (SPECT) is the most ...

January 13, 2023

StreamlineMD has provided updates for 2023 Radiology and IR CPT coding, which may impact your practice’s coding, billing, and reimbursement operations.

News | Cardiovascular Business

A Look at the Changes in 2023 to Interventional Radiology/Cardiology CPT Codes

January 5, 2023 — StreamlineMD has provided updates for 2023 Radiology and IR CPT coding, which may impact your practice ...

January 05, 2023

Mouaz Al-Mallah, MD, MSc, FASNC, 2023 ASNC President

News | ASNC

Mouaz H. Al-Mallah, MD, MSc, FASNC, Installed as ASNC’s President for 2023

January 5, 2023 — Mouaz H. Al-Mallah, MD, MSc, FASNC, director of the cardiovascular PET program at the Houston ...

January 05, 2023

This figure highlights 3 patients with a final diagnosis of low-grade uptake (Perugini grade-1). Endomyocardial biopsy results were available for the patient depicted in Panel B demonstrating ATTR-CA as the underlying pathology. Image created by Department of Nuclear Medicine, Medical University of Vienna, Austria.

News | Nuclear Imaging

Nuclear Medicine Bone Scan Study Identifies Prevalence and Outcomes of Cardiac Amyloidosis

January 5, 2023 — A new study has determined that approximately three percent of all bone scan patients have markers of ...

January 05, 2023

A team led by UTHealth Houston's K. Lance Gould, MD, (center) used PET imaging technology (shown above) to map coronary blood flow and its outcomes among heart disease patients. (Photo by UTHealth Houston)

News | PET Imaging

PET Technology More Effective Than Angiogram at Determining Need for Coronary Stents, Bypass Surgery

December 1, 2022 — A new method for determining whether patients with heart disease need coronary stents or bypass ...

December 01, 2022

Figure 1. Flow chart of machine learning workflow. A machine learning (ML) model for the prediction of vessel-specific ischemia was built, trained, and tuned in the NXT trial (Analysis of Coronary Blood Flow using CT Angiography: Next Steps). The model’s predictive performance was evaluated in the PACIFIC trial (Prospective Comparison of Cardiac Positron Emission Tomography [PET]/Computed Tomography [CT]‚ Single Photon Emission Computed Tomography [SPECT]/CT Perfusion Imaging and CT Coronary Angiography wit

News | Computed Tomography (CT)

AI Tool Predicts Reduced Blood Flow to the Heart

November 17, 2022 — Cedars-Sinai investigators and colleagues have developed an artificial intelligence (AI) tool that ...

November 17, 2022

The American Society of Nuclear Cardiology has issued an alert about possible supply disruptions

News | Radiopharmaceuticals and Tracers

Alert: Mo-99/Tc-99m Supply Disruptions Possible

Nov. 4, 2022 — On October 28, the Nuclear Medicine Europe Emergency Response Team issued a statement about mechanical ...

November 05, 2022